Generalized Lymphadenopathy due to Chronic Lymphocytic Leukemia (CLL) : 18F-FDG PET Imaging

Authors

  • Basuki Hidayat
  • Febby Hutomo
  • Ryan Yudistiro
  • Ivana D. Mulyanto
  • Hendra Budiawan
  • Johan S. Masjhur

DOI:

https://doi.org/10.28932/jmh.v1i3.520

Abstract

Lymphadenopaty is a common clinical finding with a broad differential diagnosis, withCarcinoma of Unknown Primary (CUP) as one of it’s most common causes. Flourine-18 fluoro-2 deoxy glucose (18F- FDG) positron emission tomography (PET) is a Nuclear Medicinescintigraphy procedure commonly used to localize suspected a primary lesion by depicting ametabolic status. However, in the expertise of 18F FDG PET study, clinical finding andepidemiologic data must be considered to get a better conclusion. We describe 18F-FDG PETstudy in the presence of generalized lymphadenopathy due to chronic lymphocytic leukemia(CLL), a rare disease which is initially suspected of having CUP.Keywords: 18F-FDG PET, lymphadenopathy, lymphoma, leukemia

Downloads

Download data is not yet available.

Downloads

Published

2016-02-28

How to Cite

1.
Hidayat B, Hutomo F, Yudistiro R, Mulyanto ID, Budiawan H, Masjhur JS. Generalized Lymphadenopathy due to Chronic Lymphocytic Leukemia (CLL) : 18F-FDG PET Imaging. J. Med. Health [Internet]. 2016Feb.28 [cited 2023Feb.3];1(3). Available from: https://journal.maranatha.edu/index.php/jmh/article/view/520

Issue

Section

Articles